Mostrar el registro sencillo

dc.contributor.authorLanza, Val F.
dc.contributor.authorBaquero, Fernando
dc.contributor.authorMartínez, José Luís
dc.contributor.authorRamos-Ruíz, Ricardo
dc.contributor.authorGonzález-Zorn, Bruno
dc.contributor.authorAndremont, Antoine
dc.contributor.authorSánchez-Valenzuela, Antonio
dc.contributor.authorEhrlich, Stanislav Dusko
dc.contributor.authorKennedy, Sean
dc.contributor.authorRuppé, Etienne
dc.contributor.authorSchaik, Willem van
dc.contributor.authorWillems, Rob J.
dc.contributor.authorCruz, Fernando de la 
dc.contributor.authorCoque, Teresa M.
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2019-03-20T18:46:33Z
dc.date.available2019-03-20T18:46:33Z
dc.date.issued2018
dc.identifier.issn2049-2618
dc.identifier.otherBIO2014-54507-Res_ES
dc.identifier.otherBFU2014-55534-C2-1-Pes_ES
dc.identifier.urihttp://hdl.handle.net/10902/15932
dc.description.abstractBACKGROUND: Antimicrobial resistance is a major global health challenge. Metagenomics allows analyzing the presence and dynamics of "resistomes" (the ensemble of genes encoding antimicrobial resistance in a given microbiome) in disparate microbial ecosystems. However, the low sensitivity and specificity of available metagenomic methods preclude the detection of minority populations (often present below their detection threshold) and/or the identification of allelic variants that differ in the resulting phenotype. Here, we describe a novel strategy that combines targeted metagenomics using last generation in-solution capture platforms, with novel bioinformatics tools to establish a standardized framework that allows both quantitative and qualitative analyses of resistomes. METHODS: We developed ResCap, a targeted sequence capture platform based on SeqCapEZ (NimbleGene) technology, which includes probes for 8667 canonical resistance genes (7963 antibiotic resistance genes and 704 genes conferring resistance to metals or biocides), and 2517 relaxase genes (plasmid markers) and 78,600 genes homologous to the previous identified targets (47,806 for antibiotics and 30,794 for biocides or metals). Its performance was compared with metagenomic shotgun sequencing (MSS) for 17 fecal samples (9 humans, 8 swine). ResCap significantly improves MSS to detect "gene abundance" (from 2.0 to 83.2%) and "gene diversity" (26 versus 14.9 genes unequivocally detected per sample per million of reads; the number of reads unequivocally mapped increasing up to 300-fold by using ResCap), which were calculated using novel bioinformatic tools. ResCap also facilitated the analysis of novel genes potentially involved in the resistance to antibiotics, metals, biocides, or any combination thereof. CONCLUSIONS: ResCap, the first targeted sequence capture, specifically developed to analyze resistomes, greatly enhances the sensitivity and specificity of available metagenomic methods and offers the possibility to analyze genes related to the selection and transfer of antimicrobial resistance (biocides, heavy metals, plasmids). The model opens the possibility to study other complex microbial systems in which minority populations play a relevant role.es_ES
dc.description.sponsorshipThis study was supported by the European Commission, Seven Framework Program (EVOTARFP7-HEALTH-282004 for VFL, FB, JLM, AA, DE, ER, RJLW, WvS, FdlC, and TMC), the Joint Programming Initiative in Antimicrobial Resistance (JPIAMR Third call, STARCS, JPIAMR2016-AC16/00039 to TMC, RJLW, WvS), the Joint Programming Initiative in Water (JPI Water StARE JPIW2013-089-C02-01 to JLM) and the Ministry of Economy and Competitiveness of Spain (BIO2014-54507-R to JLM, and PLASWIRES-612146/FP7-ICT-2013-10 and BFU2014-55534-C2-1-P for FdlC). The authors also acknowledge the European Development Regional Fund “A way to achieve Europe” (ERDF) for co-founding the Spanish R&D National Plan 2012-2019 (BIO2014-54507-R to JLM, PI15-0512 to TMC, PI15-00818 to FB, and BFU2014-55534-C2-1-P to FdlC), CIBER (CIBER in Epidemiology and Public Health, CIBERESP; CB06/02/0053 to FB), the Spanish Network for Research on Infectious Diseases (REIPI RD12/0015 to JLM) and the Regional Government of Madrid (InGeMICSB2017/BMD-3691). Val F. Lanza was further funded by a Research Award Grant 2016 of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). Additional funding was from the Metagenopolis grant ANR-11-DPBS-0001 to DE.es_ES
dc.format.extent14 p.es_ES
dc.language.isoenges_ES
dc.publisherBMCes_ES
dc.rightsAttribution 4.0 Internationales_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceMicrobiome. 2018 Jan 15;6(1):11es_ES
dc.subject.otherAntimicrobial Resistancees_ES
dc.subject.otherResistomees_ES
dc.subject.otherMetagenomicses_ES
dc.subject.otherDifferential Abundance Analysises_ES
dc.subject.otherTargeted Metagenomicses_ES
dc.titleIn-depth resistome analysis by targeted metagenomicses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://dx.doi.org/10.1186/s40168-017-0387-yes_ES
dc.rights.accessRightsopenAccesses_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/612146/EU/Engineering multicellular biocircuits: programming cell-cell communication using PLASmids as WIRE/PLASWIRES/es_ES
dc.identifier.DOI10.1186/s40168-017-0387-y
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International